Blood Screening Market Report Geographical Segmentation, Comprehensive Analysis to 2030
Market Overview Market Research Future (MRFR) predicts the global blood screening market to achieve a CAGR of 9.8% during the forecast period (2020-2028). Market Boosters and Key Challenges The growth of the Blood Screening Market Report is the result of the rise in the screening of donor and consistent technological advancement by the industry participants. Demand for blood screening tests has been on the rise in recent years owing to the surge in donation, boosted awareness about transfusion-transmitted diseases, and technological advancements within the industry. In addition, governments in several countries are striving to mandate testing of all the donated blood for a number of viruses. Technological developments help enhance the sensitivity and efficiency of the tests. Case in point, in 2016, the Procleix Zika virus assay developed by Hologic, Inc., and Grifols was approved by the U.S. F.D.A for screening of donated blood. Moreover, in 2013, the U.S. FDA had given approval